NCCTG N1174: Phase I/Comparative Randomized Phase II Trial of TRC105 plus Bevacizumab versus Bevacizumab in Bevacizumab-Naïve Patients with Recurrent Glioblastoma Multiforme (Alliance)
- Citation:
- J Clin Oncol vol 35 (15 suppl) abstr 2023
- Meeting Instance:
- ASCO 2017
- Year:
- 2017
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3702
- Pharmas:
- Genentech, TRACON Pharmaceuticals
- Grants:
- U10CA180821, U10CA180882
- Corr. Author:
- Authors:
- Evanthia Galanis S. Keith Anderson Nicholas Butowski Adilia MV Hormingo David Schiff David. D. Tran Antonio M. Omuro Kurt A. Jaeckle Shaji Kumar Timothy Kaufmann Caterina Giannini Erin Twohy Patrick Y. Wen
- Networks:
- CA136, LAPS-CT018, LAPS-MA036, LAPS-MN026, LAPS-MO011, VA009
- Study
- NCCTG-N1174
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 1/2
- Keywords: